From the SNM Brain Imaging Council by ProQuest


[...] a dopamine transporter radioligand may become available in the United States for a proposed indication of SPECT detection of loss of functional nigrostriatal dopaminergic neurons in patients presenting with symptoms or signs suggestive of dopaminergic neurodegeneration.

More Info
									From the SNM Brain Imaging Council
Nicolaas L Bohnen
The Journal of Nuclear Medicine; Feb 2010; 51, 2; Docstoc
pg. 18N

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

To top